Abstract Body

Background

HIV latency enables viral persistence during ART, but CTL pressure continues to shape the HIV reservoir. CD4+ T-cells exhibit varying susceptibilities to CTL attack, potentially leading to the selection of CTL-resistant HIV reservoir-harboring cells. Effective CTL-mediated killing requires the formation of an immune synapse through biophysical forces, with CTLs being more efficient at eliminating stiffer targets. HIV-Nef manipulates the host cell cytoskeleton, potentially influencing cell stiffness. Our research focuses on how cell-intrinsic heterogeneity in HIV-infected CD4+ T-cell stiffness affects susceptibility to CTLs, and the role of Nef in this process.

Methods

Central memory CD4+ T cells (Tcm) were infected with WT-JRCSF, DNef-JRCSF or TW10esc-JRCSF (CTL escape mutant) and exposed to HIV-Gag-TW10-specific CTL clones. Surviving HIV-Env+ cells were sorted and analyzed for membrane tension and stiffness using optical tweezers (OT) and atomic force microscopy (AFM). Flow cytometry assessed killing efficiency, while confocal microscopy imaged actin. Two additional mutants, NefDPAK2-JRCSF and NefDMHCI-JRCSF, were studied to differentiate Nef’s effects on cytoskeleton versus MHC-I downregulation.

Results

Without CTL, WT, DNef, and TW10esc-infected Tcm showed similar levels of membrane tension, but WT-infected cells exhibited significantly lower stiffness and F-actin levels compared to DNef. After CTL coculture, WT ‘survivors’ displayed lower membrane tension (83pN vs 129pN and 132pN; n=75, 2-donors) and stiffness (767Pa vs 1047Pa and 1233Pa; n=92, 2-donors) compared to TW10esc ‘bystanders’ and DNef survivors. NefDPAK2 (cytoskeleton interaction mutant) and NefDMHCI (MHC-I interaction mutant) -infected cells, were both much more susceptible to killing than WT. NefDMHCI survivors resembled WT survivors in low membrane tension (80pN vs 83pN; n=52, 2-donors) and stiffness (867Pa vs 767Pa; n=77, 2-donors), while NefDPAK2 survivors resembled Nef survivors (1154Pa vs 1233Pa; n=82, 2-donors), showing no evident selection.

Conclusions

Our findings reveal a collaboration between host-cell biophysical heterogeneity and HIV-Nef in promoting immunevasion. Nef reduces infected CD4+ T-cell stiffness by altering the cytoskeleton, allowing the softest cells to evade CTL-mediated killing. Therapeutics targeting cell stiffness, either by inhibiting Nef’s cytoskeletal effects or modulating host factors, may enhance elimination of CTL-resistant infected cells.